Alterity Therapeutics share price logo

Alterity Therapeutics

NASDAQ: ATHE

$1.52

-0.14

(-8.16%)

as on

Alterity Therapeutics Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's High

    $1.52
    $1.60

    5.26%

    Upside

    downward going graph
  • 52 Week's High

    $1.52
    $5.89

    287.64%

    Upside

    downward going graph

Alterity Therapeutics share price movements today

Previous Close
$1.66
Open
$1.59
Volume
542.2K
Market Cap
$31.6M
Day's Low - High
$1.52 - $1.60
52 Week Low - High
$1.52 - $5.89

Alterity Therapeutics Historical Returns

1 Month Return
-36.4 %
3 Month Return
-67.45 %
1 Year Return
-56.7 %
3 Year Return
-36.13 %
5 Year Return
-85.93 %

Alterity Therapeutics Stock Fundamentals & Key Indicators

Check Alterity Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.6M

EPS (TTM)

-1.32

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.68

Industry PE ratio

-6.85

PEG Ratio

0.10

EBITDA

-28.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-48.25%

Alterity Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$31.6M-85.93%-1.680.00%0.00%
Neutral$80.7B-26.07%-28.1528.00%0.00%
StrongBuy$45.7BNA65.0988.39%0.00%
StrongBuy$132.0B181.62%33.2585.53%0.00%
Buy$95.5B41.06%19.6585.77%0.41%

Stock Returns calculator for Alterity Therapeutics Stock including INR - Dollar returns

The Alterity Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Alterity Therapeutics investment value today

Current value as on today

₹45,016

Returns

-₹54,984

(-54.98%)

Returns from Alterity Therapeutics Stock

-₹56,695 (-56.7%)

Dollar Impact

₹1,711 (+1.71%)

Analyst Recommendation on Alterity Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Alterity Therapeutics. Average target price of $16

Alterity Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Alterity Therapeutics.

Current Price

$1.52

Analyzed by

1 Analysts

High

$16

0

Low

$16

Alterity Therapeutics target price $0, a slight upside of 0% compared to current price of $1.52. According to 1 analysts rating.

Indian Investors' Interest in Alterity Therapeutics Stock

Search interest for Alterity Therapeutics Stock has increased by 213% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:213% versus previous 30 day period

Alterity Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Total Revenue
2
2
2
1
1
2
1
3
-
-
Gross Profit
2
2
2
1
1
2
1
3
0
0
Operating Income
-10
-10
-10
-7
-4
-12
-7
-7
-12
-15
EBITDA
-8
-8
-10
-7
-8
-14
-7
-7
-12
-15
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-8
-10
-7
-4
-14
-8
-4
-12
-14
Income Tax Expense
-2
-2
-2
-1
-1
-2
-1
0
-2
0
Net Income
-6
-6
-8
-5
-6
-12
-7
-4
-9
-13
Net Profit Margin
98.66%
99.18%
97.90%
96.58%
96.11%
96.53%
96.04%
98.33%
0.00%
0.00%

Alterity Therapeutics Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
0
0
0
-
4
5
3
4
5
-
Gross Profit
0
0
0
0
3
4
3
3
5
0
Operating Income
-6
-7
-12
-10
-15
-15
-14
-19
-14
-27
EBITDA
-6
-11
-12
-13
-15
-17
-14
-19
-14
-27
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-8
-12
-10
-15
-12
-13
-19
-12
-26
Income Tax Expense
0
0
0
0
-3
0
0
0
0
-3
Net Income
-7
-8
-11
-10
-15
-12
-13
-19
-12
-22
Net Profit Margin
83.89%
89.16%
72.64%
0.00%
91.70%
92.88%
92.72%
94.67%
97.66%
0.00%

Alterity Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Net Income
-6
-6
-8
-3
-4
-12
-7
-3
-9
-13
Operating Cash Flow
-8
0
-5
-10
-4
-8
-8
-2
-10
-12
Investing Cash Flow
0
0
0
0
0
0
-
-7
7
0
Financing Cash Flow
0
0
0
0
0
8
0
25
18
1
Change in Cash
-4
2
-6
-25
-4
0
-4
15
16
-10

Alterity Therapeutics Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
-7
-8
-12
-10
-15
-12
-13
-19
-12
-22
Operating Cash Flow
-5
-6
-13
-9
-17
-12
-20
-12
-11
-22
Investing Cash Flow
0
0
0
0
0
0
0
0
-7
7
Financing Cash Flow
0
0
12
3
36
16
0
9
39
18
Change in Cash
-6
-6
0
-5
18
6
-19
-3
20
5

Global Institutional Holdings in Alterity Therapeutics

Check out the Institutions with significant holdings in Alterity Therapeutics.

Funds
Holdings
Shares Held
Peter Ashley Marks
1.00%
191340

Insights on Alterity Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 802.96K → 3.83M (in $), with an average increase of 54.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 722.1% return, outperforming this stock by 778.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 149.5% return, outperforming this stock by 157.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -4.97M → -13.97M (in $), with an average decrease of 68.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ATHE stock has moved down by -67.5%

About Alterity Therapeutics

Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
OrganisationAlterity Therapeutics
Headquarters500 Collins Street, Melbourne, VIC, 3000, AU
IndustryBiotechnology
CEODavid A. Stamler

Key Management of Alterity Therapeutics

Name

Title

Dr. David A. Stamler M.D.

CEO, MD & Director

Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.

CFO & Company Secretary

Dr. Rudolph Emile Tanzi Ph.D.

Chief Scientific Advisor and Member of Research & Development Advisory Board

Dr. Steven D. Targum M.D.

Chief Medical Advisor

Dr. Robert Cherny

Head of Research

FAQs

What is Alterity Therapeutics share price today?

Alterity Therapeutics share price today is $1.52 as on at the close of the market. Alterity Therapeutics share today touched a day high of $1.60 and a low of $1.52.

What is the 52 week high and 52 week low for Alterity Therapeutics share?

Alterity Therapeutics share touched a 52 week high of $5.89 on and a 52 week low of $1.52 on . Alterity Therapeutics stock price today i.e. is closed at $1.52,which is 74.20% down from its 52 week high and 0.00% up from its 52 week low.

What is Alterity Therapeutics's market capitalisation today?

Alterity Therapeutics market capitalisation is $0.00T as on .

How to invest in Alterity Therapeutics Stock (ATHE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alterity Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Alterity Therapeutics Stock (ATHE) from India?

Indian investors can start investing in Alterity Therapeutics (ATHE) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Alterity Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Alterity Therapeutics share’s latest price of $1.52 as on November 21, 2026 at 8:46 am IST, you will get 6.5789 shares of Alterity Therapeutics. Learn more about fractional shares .

What are the returns that Alterity Therapeutics has given to Indian investors in the last 5 years?

Alterity Therapeutics stock has given -85.93% share price returns and 25.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?